Acute Otitis Media Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Acute Otitis Media clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Evaluation of the Medentum Diagnostik Platform for Pediatric ENT Conditions and Asthma

Pediatric AsthmaAsthma ExacerbationAcute Otitis Media (AOM)+1 more
Medentum Innovations84 enrolled1 locationNCT07500532
Recruiting
Phase 2

Safety and Efficacy of wSp Vaccine in Young Children

Acute Otitis Media (AOM)
Serum Life Science Europe GmbH320 enrolled4 locationsNCT07216430
Recruiting
Not Applicable

Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care

AnginaAcute BronchiolitisAcute Bronchitis+8 more
University Hospital, Caen4,500 enrolled1 locationNCT07359287
Recruiting
Not Applicable

Artificial Intelligence Diagnostic Decision Support to Reduce Antimicrobial Prescriptions in Young Children With Colds

Acute Otitis Media (AOM)Upper Respiratory Infection
Timothy Shope300 enrolled2 locationsNCT06876259
Recruiting
Not Applicable

Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections

Ear InfectionPediatric Infectious DiseaseAcute Otitis Media
Intermountain Health Care, Inc.1,566 enrolled3 locationsNCT06034080
Recruiting
Phase 2

ATOMIC Ears: A Phase IIB randomised controlled trial to assess safety, tolerability and acceptability of a 5-day Dornase alfa treatment as an adjunct therapy to ventilation tube insertion for otitis media in children

Recurrent acute otitis mediaChronic otitis media with effusion ("glue ear")
Telethon Kids Insitute120 enrolled5 locationsACTRN12619001306101
Recruiting
Phase 3Phase 4

Antibtiotics for Asymptomatic Acute Otitis Media

Acute otitis media without perforation
Menzies School of Health Research300 enrolled1 locationACTRN12608000424303